At Sanofi, we’re looking beyond relapses and acute lesions to advance our understanding of MS. We’re currently exploring an important unmet need: the role of smoldering neuroinflammation in disease progression and disability accumulation.
As part of our commitment to illuminating scientific breakthroughs in MS, we’re excited to host “Understanding Microglia: A Key Driver of Smoldering Neuroinflammation.” Join expert neurologists Massimo Filippi, MD, FEAN, FAAN and Heinz Wiendl, MD, PhD, FEAN, FAAN on 11 October, at 17:30 in the Red Room to hear them discuss the role of smoldering neuroinflammation in disability accumulation and its physical and cognitive impact on your patients.
Watch the video to see what happens when smoldering neuroinflammation in MS is left unaddressed.
We look forward to seeing attendees interested in learning more about smoldering neuroinflammation at the Sanofi booth where we can convene, connect, and explore this hot topic. In the meantime, stay current with MS at SmolderingMS.com.